ADVERTISEMENT
News
Hypertension Capsules Pulled
02/28/2019
The recall affects 100-count bottles (NDC 0378-5280-01) and 500-count bottles (NDC 0378-5280-05) from lot 3090167 (Exp. 10/19). The affected bottles were distributed throughout the United States.
Mylan Pharmaceuticals voluntarily initiated the recall February 13, 2019. Two days later, the FDA designated it Class III, suggesting use of the affected capsules is not likely to cause harm.
Diltiazem hydrochloride is a prescription calcium channel blocker used to treat patients with hypertension and chest pain.
—Jolynn Tumolo
Stay Informed & Sign Up Today
Pharmacy Learning Network Newsletter
